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ABSTRACT
Background: Existing evidence should provide ethical, scientific and environmental justification for new randomised 
trials and users of the findings of these trials need to see them in the context of similar trials. Since 1997, audits have been 
done of reports of randomised trials in Annals of Internal Medicine, BMJ, JAMA, Lancet, and New England Journal of 
Medicine to see if results are placed in context in the Discussion section of the report and, since 2005, to see if systematic 
reviews are used in the Introduction section.
Methods: We handsearched each May 2012 issue of these five journals to identify reports of randomised trials. Introduction 
and Discussion sections were categorised on the basis of their use of systematic reviews.
Results: Thirty-five reports of randomised trials were included. Considering the Introduction sections: 5 were said to be 
the first trial, 1 used an updated systematic review in the design, 13 discussed previous systematic reviews, 10 mentioned 
other trials, and 6 didn’t mention other trials or claim to be the first. Considering the Discussion sections: 2 were said to 
be the first trial, 2 contained a systematic review integrating the new trial, 11 mentioned a systematic review, and 20 made 
no apparent systematic attempt to place findings in full context. There was variability across the journals, with reports in 
the Lancet making notably more use of systematic reviews.                                                                                                             
Conclusions: Many trials still do not use systematic reviews in their design and reporting.
BACKGROUND
The scientific, ethical and environmental justification for 
any new study should be a systematic review of the relevant 
research that already exists. This avoids waste that would 
come from seeking to answer a question with the new 
study that had been answered reliably by earlier studies, 
and should help to ensure that the new study is designed in 
a way that learns from successes and failures of the past.1 
When the study’s findings are reported, these should be 
presented to readers within an updated systematic review 
of similar studies, to avoid undue emphasis solely on the 
results of the new study, to maximise the value of past 
studies (including the one being reported for the first time), 
and to provide the reader with a summary of all the relevant 
evidence.2 In the Explanation and Elaboration document for 
the most recent CONSORT statement in 2010, the authors 
“recommend that, at a minimum, the discussion should be 
as systematic as possible and be based on a comprehensive 
search, rather than being limited to studies that support the 
results of the current trial.”3 Unfortunately, despite some 
progress towards achieving these goals, the healthcare 
literature still includes many reports of randomised trials 
that do not meet these standards. This study, which updates 
earlier audits, was conducted in 2012 to provide up-to-date 
data for a series of papers highlighting problems in, and 
suggesting solutions for, waste in research.
The earlier audits were conducted in May 19974, 20015, 
20056, and 2009.7 Those audits assessed a total of 106 
reports of randomised trials from Annals of Internal 
Medicine, BMJ, JAMA, Lancet and the New England 
Journal of Medicine. The findings of the new trial were 
integrated into a systematic review in three (3%) of these 
(all published in the Lancet), and 22 (21%) cited a previous 
systematic review but did not integrate the findings of the 
trial. Considering the other 81 reports, 12 (11%) appeared 
to be the first trial and, hence, the totality of the evidence 
for the purpose of this audit. However, even though the 
reports of the other 69 (65%) trials included citations to 
trials, they did not provide information to suggest that these 
citations arose from a systematic attempt to set the results 
of the new trial in context.7 Therefore, across a dozen years 
of these high profile journals, most reports of randomised 
trials had failed to provide the reader with sufficient 
information to assess the contribution of the new trial to the 
totality of the evidence base, and, as a consequence, failed 
to provide the reliable and robust evidence needed to help 
people make well-informed decisions and choices about the 
healthcare interventions that had been evaluated. However, 
alongside the publication of our 2009 audit in the Lancet,7 
an editorial by Clark and Horton outlined a new policy for 
that journal in which authors of all research studies, not just 
randomised trials, would be asked to include an updated 
systematic review in their Discussion section.8 This led 
to the inclusion of a box in research reports in the Lancet 
that allows authors to describe a systematic review which 
integrates their findings. 
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The inclusion of a systematic review in the Introduction 
section of the report of a randomised trial provides an 
indication that the new trial had been designed and 
conducted with due consideration to existing research. This 
aspect of our research began in a limited way in 2005 and 
was extended in 2009. Of the 47 reports of trials published 
in the five journals in May of those two years, 16 (34%) 
mentioned a systematic review in their Introduction.7 Recent 
work by Jones et al. has found that 37 of 48 randomised 
trials funded by the UK’s National Institute for Health 
Research Health Technology Assessment (NIHR HTA) 
programme in 2006-2008, referenced a systematic review 
in the application, with 20 of these using information from 
the systematic review in the design or planning of the new 
trial.9
METHODS
We repeated the audit in May 2012. As in each of the 
previous studies, we focused on how well the Discussion 
section of each report placed the results of the new trial 
in the context of other relevant research. As in the 2009 
audit, we also investigated whether the reports included 
information about systematic reviews or other trials in their 
Introduction section. 
We continued with our earlier definition of “trial,” which 
is based on the definition of randomised and quasi-
randomised trials used by The Cochrane Collaboration: 
“the individuals (or other units) followed in the trial were 
assigned prospectively to one of two (or more) alternative 
forms of health care using random allocation or some quasi-
random method of allocation (such as alternation, date of 
birth, or case record number).”7 Eligible reports were those 
published as a full article or paper which was principally 
concerned with providing findings for the outcomes studied 
in the trial and was published in one of the five target 
journals during May 2012. 
Both authors handsearched the relevant issues of the 
journals independently to identify eligible reports. The 
Introduction and Discussion sections of each eligible report 
were then assessed independently by both authors to decide 
whether an updated systematic review was included, or 
whether reference was made to a systematic review of direct 
relevance to the comparison of interventions assessed in 
the trial. We discussed our findings and reached agreement 
on all coding.
FINDINGS
We identified 35 reports of randomised trials across the five 
journals. The findings for the Introduction and Discussion 
sections are shown in Tables 1 and 2, along with data from 
previous audits. We found one eligible report in Annals of 
Internal Medicine, three in BMJ, seven in JAMA, nine in 
Lancet and 15 in New England Journal of Medicine.
Considering the Introduction sections, 5 (14%) of the 35 
reports claimed to be the first trial at the time the study was 
initiated. The use of an updated systematic review to design 
the trial was referred to the Introduction section of one 
(3%) report, and 13 (37%) discussed previous systematic 
reviews. Ten (29%) reports mentioned others trials in their 
Introduction and 6 (17%) did not mention other trials or 
claim to be the first.
Turning to the Discussion sections, 2 (6%) of the 35 trials 
said that they were the only trial of the topic. Two (6%) 
reports contained a systematic review integrating the new 
trial10, 11 and 11 (31%) mentioned a systematic review. 
Twenty (57%) made no apparent systematic attempt to 
place findings in full context. 
A particularly noticeable difference to earlier years is that 
the proportion of reports of randomised trials in the Lancet, 
which either integrated the results of the new trial into a 
systematic review or mentioned a systematic review in 
their Discussion, now stands at 86% (6 of 7) of reports of 
randomised trials that did not claim to be the only trial, with 
one of these integrating the findings of the new trial into 
a systematic review. (Two reports of trials in the Lancet 
claimed to be the only trial in the Discussion section.) In 
contrast, nine (60%) of 15 reports of randomised trials in the 
New England Journal of Medicine in May 2012 appeared 
to make no systematic attempt to place the findings of the 
new trial in the context of reports of other, similar studies.
DISCUSSION
Considering all five of these general medical journals 
together, there appears to be relatively little evidence of 
progress in regard to the integration of the findings of new 
trials into an updated systematic review. Furthermore, 
the proportion of trials referring to systematic reviews 
in their Discussion section (with or without integration 
of the new trial’s findings) appears not to be increasing. 
Excluding trials that appeared to be the only trial in the 
Table 1. Classification of Introduction sections 
in reports of randomised published in May 2009 
and May 2012 in Annals of Internal Medicine, 
BMJ, JAMA, Lancet, and New England Journal of 
Medicine
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topic area, the proportion was 24% of reports in 1997, 10% 
in 2001, 33% in 2005, 46% in 2009 and 39% in 2012. This 
is despite the fact that there are now more than 5000 full 
Cochrane Reviews in the Cochrane Database of Systematic 
Reviews12 and several thousand more systematic reviews 
are published each year in other places.13, 14 However, there 
is considerable heterogeneity across the five journals in this 
sample, which will be explored further in a future report of 
the 2013 audit.
In summary, this latest update of the “islands” project 
shows that many randomised trials still do not place their 
findings in the context of an up-to-date systematic review 
of other relevant evidence, and that only one of the five 
high profile medical journals we studied, the Lancet, is 
achieving this for most of the trial reports that it publishes. 
However, that journal’s introduction of a dedicated box 
to research articles for an outline of the findings of a 
relevant systematic review and the recent publication of an 
extension to the PRISMA Statement covering the reporting 
of systematic reviews in abstracts15 show that it is possible 
to report key elements from a systematic review within the 
confines of an article for which the main focus is the new 
randomised trial. This, coupled with the increasing uptake 
of the CONSORT reporting guidelines,16 will hopefully 
lead to benefits for the users of reports of randomised trials.
REFERENCES
1. Clarke M. Doing new research? Don’t forget the old. Nobody 
should do a trial without reviewing what is known. PLoS 
Med. 2004 1(2):100-02.
2. Chalmers I, Altman DG. How can medical journals help 
prevent poor medical research? Some opportunities presented 
by electronic publishing. Lancet. 1999 Feb 6;353(9151):490- 
3.
3. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, 
Devereaux PJ, et al. CONONSORT 2010 explanation and 
elaboration: updated guidelines for reporting parallel group 
randomised trials. BMJ. 2010 Mar 23;340:c869.
4. Clarke M, Chalmers I. Discussion sections in reports of 
controlled trials published in general medical journals: islands 
in search of continents? JAMA. 1998 Jul 15;280(3):280-2.
5. Clarke M, Alderson P, Chalmers I. Discussion sections in 
reports of controlled trials published in general medical 
journals. JAMA. 2002 Jun 5;287(21):2799-801.
6. Clarke M, Hopewell S, Chalmers I. Reports of clinical trials 
should begin and end with up-to-date systematic reviews of 
other relevant evidence: a status report. J R Soc Med. 2007 
Apr;100(4):187-90.
7. Clarke M, Hopewell S, Chalmers I. Clinical trials should 
begin and end with systematic reviews of relevant evidence: 
12 years and waiting. Lancet. 2010 Jul 3;376(9734):20-1.
8. Clark S, Horton R. Putting research into context – revisited. 
Lancet. 2010 Jul 3;376(9734):10-11.
9. Jones AP, Conroy E, Williamson PR, Clarke M, Gamble C. 
The use of systematic reviews in the planning, design and 
conduct of randomised trials: a retrospective cohort of NIHR 
HTA funded trials. BMC Med Res Methodol. 2013 Mar 
25;13:50.
10. Merry SN, Stasiak K, Shepherd M, Frampton C, Fleming T, 
Lucassen MFG. The effectiveness of SPARX, a computerised 
self help intervention for adolescents seeking help for 
depression: randomised controlled non-inferiority trial. BMJ. 
2012 Apr 18;344:e2598.
11. Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina 
L, Rosman C, Garcia JR, et al. Minimally invasive versus 
open oesophagectomy for patients with oesophageal cancer: 
a multicentre, open-label, randomised controlled trial. 
Lancet. 2012 May 19;379(9829):1887-92.
12. Clarke M, Li Y. Editorial for Issue 2 2012. Journal of 
Evidence Based Medicine. J Evid Based Med. 2010;5:47.
13. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. 
Epidemiology and reporting characteristics of systematic 
reviews. PLoS Med. 2007 Mar 27;4(3):e78.
14. Bastian H, Glasziou P, Chalmers I. Seventy-five trials and 
eleven systematic reviews a day: how will we ever keep up? 
PLoS Med. 2010 Sep 21;7(9):e1000326.
Table 2. Classification of Discussion sections in reports of randomised
published in May 1997, May 2001, May 2005, May 2009 and May 2012 in Annals
of Internal Medicine, BMJ, JAMA, Lancet, and New England Journal of Medicine
J Bahrain Med Soc 2013 Vol. 24 No. 3148
15. Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, 
Chalmers I, et al. PRISMA for abstracts: reporting systematic 
reviews in journal and conference abstracts. PLoS Med. 2013 
10(4):e1001419.
16. Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, 
et al. Consolidated standards of reporting trials (CONSORT) 
and the completeness of reporting of randomised controlled 
trials (RCTs) published in medical journals. Cochrane 
Database Syst Rev. 2012 Nov 14;11:MR000030.
Professor Mike Clarke
Director, All-Ireland Hub for Trials Methodology Research 
Centre for Public Health 
Institute of Clinical Sciences, Block B 
Queens University Belfast 
Royal Hospitals
Grosvenor Road
Belfast BT12 6BJ 
Northern Ireland
Phone: +44 (0)28 90635059 
Fax: +44 (0)28 90235900
